- Home
- TENX vs PRPO Comparison
TENX vs PRPO Comparison
Compare TENX & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- PRPO
- Stock Information
- Founded
- TENX 1967
- PRPO N/A
- Country
- TENX United States
- PRPO United States
- Employees
- TENX N/A
- PRPO N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- TENX Health Care
- PRPO Industrials
- Exchange
- TENX Nasdaq
- PRPO Nasdaq
- Market Cap
- TENX 25.8M
- PRPO 22.0M
- IPO Year
- TENX N/A
- PRPO N/A
- Fundamental
- Price
- TENX $5.84
- PRPO $13.80
- Analyst Decision
- TENX Strong Buy
- PRPO
- Analyst Count
- TENX 3
- PRPO 0
- Target Price
- TENX $16.00
- PRPO N/A
- AVG Volume (30 Days)
- TENX 23.2K
- PRPO 8.1K
- Earning Date
- TENX 08-19-2025
- PRPO 08-14-2025
- Dividend Yield
- TENX N/A
- PRPO N/A
- EPS Growth
- TENX N/A
- PRPO N/A
- EPS
- TENX N/A
- PRPO N/A
- Revenue
- TENX N/A
- PRPO $20,029,000.00
- Revenue This Year
- TENX N/A
- PRPO N/A
- Revenue Next Year
- TENX N/A
- PRPO N/A
- P/E Ratio
- TENX N/A
- PRPO N/A
- Revenue Growth
- TENX N/A
- PRPO 26.67
- 52 Week Low
- TENX $3.25
- PRPO $3.90
- 52 Week High
- TENX $7.89
- PRPO $16.89
- Technical
- Relative Strength Index (RSI)
- TENX 39.80
- PRPO 49.26
- Support Level
- TENX $5.80
- PRPO $13.92
- Resistance Level
- TENX $6.25
- PRPO $14.65
- Average True Range (ATR)
- TENX 0.24
- PRPO 0.36
- MACD
- TENX -0.04
- PRPO -0.21
- Stochastic Oscillator
- TENX 7.22
- PRPO 0.00
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.